Clinical Progress of Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Fuente:
Zenodo
Saved in:
| Main Authors: | Xiao, Boya, Zhang, Zhanjie, Kuang, Bohua, Cao, Rubo, Wang, Bicheng |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2021
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Efficacy and Safety of Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Meta‐Analysis of Phase III Randomized Trials With Subgroup Analysis by Neoadjuvant Chemotherapy
by: Wala Ben Kridis, et al.
Published: (2025)
by: Wala Ben Kridis, et al.
Published: (2025)
Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study
by: Wan‐Ping Guo, et al.
Published: (2024)
by: Wan‐Ping Guo, et al.
Published: (2024)
Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
by: Emergency Medicine International
Published: (2024)
by: Emergency Medicine International
Published: (2024)
UHS Chemotherapy Adjuvant
by: V
Published: (2026)
by: V
Published: (2026)
Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma
by: Ying‐peng Peng, et al.
Published: (2024)
by: Ying‐peng Peng, et al.
Published: (2024)
Prognostic Value of Pre‐Treatment Diffusion Kurtosis Imaging for Progression‐Free Survival Prediction in Advanced Nasopharyngeal Carcinoma
by: Wang Ren, et al.
Published: (2025)
by: Wang Ren, et al.
Published: (2025)
Development and Validation of a Multi‐Omics Model Integrating MR Radiomics and Immune Scores for Prognostic Prediction in Locally Advanced Nasopharyngeal Carcinoma
by: Zhun Zhong, et al.
Published: (2025)
by: Zhun Zhong, et al.
Published: (2025)
Impact of Clinical Surveillance on Outcomes of Locally Recurrent Nasopharyngeal Carcinoma
by: Tsinrong Lee, et al.
Published: (2025)
by: Tsinrong Lee, et al.
Published: (2025)
A Practical Online Dynamic Nomogram to Predict the Progression‐Free Survival in Nasopharyngeal Carcinoma
by: Jiayan Zhang, et al.
Published: (2025)
by: Jiayan Zhang, et al.
Published: (2025)
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma
by: Yoon Soo Chae, et al.
Published: (2025)
by: Yoon Soo Chae, et al.
Published: (2025)
Radiotherapy Planning for Nasopharyngeal Carcinoma After Induction Chemotherapy: A Systematic Review to Inform Consensus Guideline Development
by: Omar Nouri, et al.
Published: (2025)
by: Omar Nouri, et al.
Published: (2025)
SMURF1 Regulates CTCF ‐ HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma
by: Ying Jin, et al.
Published: (2026)
by: Ying Jin, et al.
Published: (2026)
The Treatment of Primary Lymphoepithelioma‐Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma
by: Qiaohong Lin, et al.
Published: (2024)
by: Qiaohong Lin, et al.
Published: (2024)
Nasopharyngeal Carcinoma in Intensity‐Modulated Radiation Therapy Era: Competing‐Risk Analysis, Recurrence, and Postrecurrence Survival
by: Chun‐Wei Wang, et al.
Published: (2025)
by: Chun‐Wei Wang, et al.
Published: (2025)
Divergent Survival Outcomes With Adjuvant Chemotherapy in Stage IA Ovarian Clear Cell Carcinoma: Insights From the SEER Database
by: Luping Pan, et al.
Published: (2025)
by: Luping Pan, et al.
Published: (2025)
Efficacy of Maintenance Therapy With Adjuvant Chemotherapy of Three Steps in Patients Newly Diagnosed With Advanced Ovarian Cancer: A Phase II Randomised Clinical Trial
by: Zhong Zheng, et al.
Published: (2025)
by: Zhong Zheng, et al.
Published: (2025)
Nomograms Based on Blood‐Based Biomarkers for Predicting Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients
by: Sisi Wang, et al.
Published: (2025)
by: Sisi Wang, et al.
Published: (2025)
Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma
by: Vivek C. Pandrangi, et al.
Published: (2025)
by: Vivek C. Pandrangi, et al.
Published: (2025)
Visceral Adipose Predicts Prognosis and Toxicities in Locally Advanced Bladder Cancer Patients Treated With Adjuvant Gemcitabine Plus Cisplatin Chemotherapy
by: Zhimin Gao, et al.
Published: (2025)
by: Zhimin Gao, et al.
Published: (2025)
FOLR1 Mediated by ITCH Promotes Paclitaxel Resistance by Suppressing Pyroptosis in Nasopharyngeal Carcinoma
by: Gehou Zhang, et al.
Published: (2026)
by: Gehou Zhang, et al.
Published: (2026)
Symptom Clusters in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Systematic Review
by: Yishu Qi, et al.
Published: (2024)
by: Yishu Qi, et al.
Published: (2024)
The Combined Treatment of 4EGl‐1 and MK‐2206 Inhibits Nasopharyngeal Carcinoma Progress by Inducing Autophagy
by: Yinghuan Dai, et al.
Published: (2025)
by: Yinghuan Dai, et al.
Published: (2025)
Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer
by: Dongxu Lei, et al.
Published: (2025)
by: Dongxu Lei, et al.
Published: (2025)
A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma
by: Ming Zhang, et al.
Published: (2025)
by: Ming Zhang, et al.
Published: (2025)
Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
by: Siyu Zhu, et al.
Published: (2024)
by: Siyu Zhu, et al.
Published: (2024)
Treatment Adequacy and Baseline Risk Modify the Association Between Adjuvant Chemotherapy and Survival After Pathological Complete Response in Rectal Cancer
by: Chentong Wang, et al.
Published: (2026)
by: Chentong Wang, et al.
Published: (2026)
Efficacy and Failure Patterns Following Target Volume and Dose Reduction After Neoadjuvant Therapy in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
by: Xiong Zhou, et al.
Published: (2024)
by: Xiong Zhou, et al.
Published: (2024)
Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population‐Based Large Cohort Study
by: Lixi Li, et al.
Published: (2025)
by: Lixi Li, et al.
Published: (2025)
Correction to “The Treatment of Primary Lymphoepithelioma‐Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma”
Published: (2025)
Published: (2025)
Molecular Functions and Drug Prediction of MMP1 and TGFBR2 in Nasopharyngeal Carcinoma
by: Feng Wang, et al.
Published: (2026)
by: Feng Wang, et al.
Published: (2026)
Locoregional therapies for cholangiocarcinoma: Where they stand?
by: Ángeles García‐Criado, et al.
Published: (2024)
by: Ángeles García‐Criado, et al.
Published: (2024)
CircCGNL1 Suppresses Nasopharyngeal Carcinoma Progression by Targeting IGF2BP3 and Inhibiting AKT/mTOR Signaling
by: Ting Li, et al.
Published: (2025)
by: Ting Li, et al.
Published: (2025)
Targeting Ferroptosis in Nasopharyngeal Carcinoma: Mechanisms of Therapy Resistance and Therapeutic Opportunities
by: Dayuan Zheng, et al.
Published: (2025)
by: Dayuan Zheng, et al.
Published: (2025)
Efficacy and Safety of Curcumin as an Adjuvant to Standard Chemotherapy in Advanced and Metastatic Breast Cancer Patients: A Randomized Controlled Study
by: Shekhar Goyal, et al.
Published: (2025)
by: Shekhar Goyal, et al.
Published: (2025)
Effect of Radiotherapy on Vestibular Function Among Nasopharyngeal Carcinoma Patients
by: Pei Fen Cheah, et al.
Published: (2025)
by: Pei Fen Cheah, et al.
Published: (2025)
Characterizing and Targeting of BCL‐2 Family Members in Nasopharyngeal Carcinoma
by: A. A. Thai, et al.
Published: (2024)
by: A. A. Thai, et al.
Published: (2024)
Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication
by: Nicholas Brian Shannon, et al.
Published: (2025)
by: Nicholas Brian Shannon, et al.
Published: (2025)
Postoperative Adjuvant Chemoradiotherapy ± PD ‐1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma
by: Zhiqiang Wang, et al.
Published: (2026)
by: Zhiqiang Wang, et al.
Published: (2026)
Subsequent Survival and Loss of Lifetime for Patients With Progression‐Free 24 Months After Treatment in Nasopharyngeal Carcinoma: A Comprehensive Nationwide Population‐Based Analysis
by: Yang Liu, et al.
Published: (2025)
by: Yang Liu, et al.
Published: (2025)
Association Between Nasopharyngeal Carcinoma and Chinese Medicine Constitution: A Meta‐Analysis
by: Shun‐Qi Chen, et al.
Published: (2026)
by: Shun‐Qi Chen, et al.
Published: (2026)
Similar Items
-
Efficacy and Safety of Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Meta‐Analysis of Phase III Randomized Trials With Subgroup Analysis by Neoadjuvant Chemotherapy
by: Wala Ben Kridis, et al.
Published: (2025) -
Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study
by: Wan‐Ping Guo, et al.
Published: (2024) -
Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
by: Emergency Medicine International
Published: (2024) -
UHS Chemotherapy Adjuvant
by: V
Published: (2026) -
Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma
by: Ying‐peng Peng, et al.
Published: (2024)